ANALYSIS OF ANTIBIOTIC RESISTANCE OF OPPORTUNISTIC MICROFLORA ISOLATED FROM COMMUNITY-ACQUIRED PNEUMONIA

Authors

DOI:

https://doi.org/10.11603/1681-2727.2020.3.11454

Keywords:

resistance to antibiotics, opportunistic bacteria, pneumoniae

Abstract

The aim of the research was to study the sensitivity to antibiotics of the microflora isolated from patients with community-acquired pneumonia.

Patients and methods. The results of bacteriological researches of bronchial lavage fluid and sputum from 336 patients with community-acquired pneumonia were used in the work.

Results. Studies have shown absolute susceptibility of staphylococci to clarithromycin and ampicillin, S. pyogenes to ciprofloxacin, azithromycin, clarithromycin, ceftriaxone and chloramphenicol, S. anhaemolyticus to ampicillin, amoxiclav, penicillin, cefoperazone, clindamycin, clarithromycin, chloramphenicol and amikacin, S. pneumoniae to amoxiclav, cefoperazone, ceftriaxone, levofloxacin, clarithromycin, azithromycin, imipenem, and vancomycin. Streptococci of the viridans group were sensitive to chloramphenicol in 93 % of cases, and they were resistant to other antibiotics in 30–84 % of cases.

Most of the studied strains of coccal microflora were resistant to other antibiotics. Thus, 33 to 72 % of strains showed resistance to meronem, 12–46 % to imipenem, 61–90 % to oxacillin, 33–71 % to ceftazidime, 18–56 % to cefepime, and 25–48 % of strains to azithromycin, 25–46 % to levofloxacin. All studied strains of P. aeruginosa were resistant to ampicillin, oxacillin, amoxiclav, ceftazidime, cefepime and sensitive to other antibiotics ranged from 5 to 38 % of strains.

Fungi of the genus Candida showed the greatest sensitivity to nystatin (88.1 %). Clotrimazole was effective in 40.3 % of cases, ketoconazole – in 39.2 %. The lowest activity was in amphotericin (13.6 %), itraconazole (11.9 %) and fluconazole (11.4 %).

Conclusion. Thus, there is an increase in the resistance of the fungi of genus Candida to triazole antifungals and the bacterial flora isolated from patients with community-acquired pneumonia to fluoroquinolones, aminopenicillins, cephalosporins, macrolides (azithromycin), while maintaining its sensitivity to clarithromycin.

Author Biographies

N. I. Kovalenko, Kharkiv National Medical University

PhD (Biology), Associate Professor of the D.P. Hryniov Microbiology, Virology and Immunology Department, Kharkiv National Medical University

T. M. Zamaziy, Kharkiv National Medical University

PhD (Medicine), Associate Professor of D.P. Hryniov Microbiology, Virology and Immunology Department, Kharkiv National Medical University

I. V. Novikova

Head of a Multidisciplinary Clinical Diagnostic Laboratory, Municipal Non-profit Enterprise of the Kharkiv Regional Council “Regional Clinical Hospital”, Kharkiv

References

Adapted evidence-based clinical guideline (2019). Nosocomial pneumonia in adults: etiology, pathogenesis, classification, diagnosis, antimicrobial therapy and prevention. Kyiv: National Academy of Medical Sciences of Ukraine [in Ukrainian].

World Health Organization. (2019). World Health Statistics. Retrieved from: https://apps.who.int/iris/bitstream/handle/10665/311696/WHO-DAD-2019.1-eng.pdf?ua=1.

(2020). State Statistics Service of Ukraine. Health care. Retrieved from: http:// www.ukrstat.gov.ua

Nan, D., Jialin, D., Chenwei, H., & Haixia, L. (2020). Microbial distribution and antibiotic susceptibility of lower respiratory tract infections patients from pediatric ward, adult respiratory ward, and respiratory intensive care unit. Front Microbiol., 30 (11), 1480. DOI: 10.3389/fmicb.2020.01480. DOI: https://doi.org/10.3389/fmicb.2020.01480

Dickson, R.P., Erb-Downward, J.R., Martinez, F.J., & Huffnagle, G.B. (2016). The Microbiome and the respiratory tract. Annu. Rev. Physiol., 78, 481. Retrieved from: https://pubmed.ncbi.nlm.nih.gov/26527186/.

Rachina, S.A., Kozlov, R.S., Dekhnich, N.N., Bobylev, A.A., & Barashko, O.D. (2015). Antibiotic therapy for severe community-acquired pneumonia in adults: review of guidelines and clinical examples. Arkhiv vnutrenney meditsiny – Archive of Internal Medicine, 23, 3, 63-64 [in Russian].

Zyryanov, S.K., & Butranova, O.I. (2019). Modern approaches to the choice of an antibiotic for the treatment of community-acquired pneumonia in various categories of patients. Kachestvennaya klinicheskaya praktika – Good Clinical Practice, 1, 97-113 [in Russian].

(2007). Order of the Ministry of Health of Ukraine No. 167 dated April 05, 2007. About the statement of methodical instructions “Determination of sensitivity of microorganisms to antibacterial drugs”. Кyiv [in Ukrainian].

Kovalenko, N.I., Zamaziy, T.M., Novikova, I.V., Taranenko, H.P. (2019). Ecological analysis of opportunistic pathogenic microflora in pneumonia. Eastern Ukrainian Medical Journal, 7(2), 136-141 [in Ukrainian]. DOI: https://doi.org/10.21272/eumj.2019;7(2):136-141

Metlay, J.P., Waterer, G.W., Long, A.C., Anzueto, A., Brozek, J., Crothers, K., ... Metlay, C.G. (2019). Diagnosis and treatment of adults with community-aquired pneumoniae. An Official Clinical Practice Guideline of the American Thoratic Society and Infectious Diseases Society of America. Am. J. Respir. Crit. Care Med., 1, 200 (7), 45-67. DOI: 10.1164/rccm.201908-1581ST. DOI: https://doi.org/10.1164/rccm.201908-1581ST

Published

2020-12-03

How to Cite

Kovalenko, N. I., Zamaziy, T. M., & Novikova, I. V. (2020). ANALYSIS OF ANTIBIOTIC RESISTANCE OF OPPORTUNISTIC MICROFLORA ISOLATED FROM COMMUNITY-ACQUIRED PNEUMONIA. Infectious Diseases – Infektsiyni Khvoroby, (3), 44–49. https://doi.org/10.11603/1681-2727.2020.3.11454

Issue

Section

Original investigations